Zollinger-Ellison Syndrome
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
TM
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Trio MedicinesYF476
Clinical Trials (1)
YF476 and Type II Gastric Carcinoids
Start: Apr 2011Est. completion: Jun 2012
Phase 2Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space